Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
about
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingLeft ventricular geometric patterns in newly presenting Nigerian hypertensives: an echocardiographic studyRole of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial HypertensionCardiac remodelling and RAS inhibitionThe HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesEpidemiology of left ventricular hypertrophy in hypertension: implications for the clinic.Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of HypertensionThe Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status.Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?Successful treatment of hypertension accounts for improvements in markers of diastolic function - a pilot study comparing hydrochlorothiazide-based and amlodipine-based treatment strategiesBlood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease.ACE2 improves right ventricular function in a pressure overload model.Indicators and treatment of hypertensive heart disease.Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diureticsPrehypertension: Underlying pathology and therapeutic options.The fixed combination of verapamil SR/trandolapril.Valsartan: a novel angiotensin type 1 receptor antagonist.Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications.White coat effect and white coat hypertension: one and the same?Prescribing of Antihypertensive Agents in Public Primary Care Clinics - is it in Accordance with Current Evidence?Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.Ongoing trials involving angiotensin-converting enzyme inhibitors.Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension.New paradigms in preventive cardiology: unconventional coronary risk factorsRegression of left ventricular hypertrophy: hoping for a longer life.Implications of the LIFE trial.ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?Risk-benefit assessment of angiotensin II receptor antagonists.Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy-a Randomised Intervention Trial with losartan)Impact of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers on mortality of coronary artery bypass grafting.Reversal of experimental renovascular hypertension restores coronary microvascular function and architectureExpression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophyAntihypertensive medications for risk reduction of first and recurrent ischemic stroke.Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.Moexipril and left ventricular hypertrophyAngiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
P2860
Q21284671-1AA7E8D6-D13E-41F3-96D4-2F3DDF1C8EC3Q25255176-8DCC3047-B3FE-4BAE-9EFC-D46F9F8E81D0Q26747017-61AAC372-D07F-4BDF-BA34-500E4575957BQ28076749-04676EAB-075B-47FC-BFFD-A49E6667F1C6Q28188518-F8C35A9E-CE32-4CC0-8298-1DC7F8B3FE99Q30250365-CEEAE43A-C3AF-4CC9-8246-CF11DB4E4BBEQ30499043-6AF05C7D-F820-473C-8D2F-34A40079880FQ30499045-A6EBB0E3-9559-4387-92E6-90785C4B61F4Q32100635-9560A2BF-5E91-4750-A8FE-FF2AD1A39DECQ33586708-FA7B069A-AEDA-4AD1-9108-7D4A4DAE902BQ33595934-5F6DE4FE-4527-41BD-9BC0-C3246D69FFB9Q33643752-1397D5DA-2FFD-4C92-8069-CB26757227C8Q33928332-52C60D3D-2F67-4227-BA82-3348C0C130EFQ33939495-336FFC6E-0FED-45B9-B33B-1BE61A85FBF5Q33972839-2B2B96CF-F5DB-4ED7-BC64-8BB63E9F164FQ33987849-0EE46091-5E86-48E6-87C6-983E35789668Q34179007-9B041BC5-47FE-4544-B336-A0C4D4811E9CQ34182205-BACB791D-5538-431B-996F-7CD81CC4E2CEQ34182288-8DA9335D-9E52-4F78-B9D0-E913E597F3FDQ34200319-4B83BF2B-2FF2-4F6E-B5A4-8F8E0F5B494DQ34220625-502DE928-0CA4-4C0E-83B3-8E31D29B8ADBQ34220716-369E235F-5B95-495B-AB15-B5EC21020436Q34586729-4FEE8ED7-9D5B-4885-B418-B8707DF4C5D0Q34849534-0A84D636-B7C0-4577-B07D-E9B8AEA65787Q35001043-57FAA509-696B-49A6-BBB5-227F6CD9A174Q35043124-2953FE45-25B7-4635-8998-9DD4124FA4C5Q35052188-0288183C-BC9D-419B-B43D-EF0E67409310Q35058619-8FA58145-2F85-4E07-B01E-14A092C7E65BQ35117105-6A4D3BE9-F05B-4018-B4D8-03C2A96907D7Q35154543-D440E97E-C816-4937-B7B7-75C0686EE2C0Q35194507-45A4ECD3-C799-4158-8703-1C68D8532429Q35215135-B92D046F-62B5-4702-8671-4688F5F4E44BQ35217983-A47BFD8F-65B2-4292-9793-74C09402E634Q35617259-75DE3F55-349F-495C-9832-BBDBCBAADF5BQ35628592-E9B4A588-21E5-481E-8C48-8C20F7694838Q35801335-06588A49-FC7A-4494-ADF2-779621E84326Q35925696-454C8826-FD33-414D-AA0A-A2A53994E901Q35934274-4E80CD7B-B76E-4236-9836-AA8DA45C663FQ36013111-675292E1-8811-4428-BC43-0124007F6AADQ36050466-485EC93D-F2B6-4AED-BFD0-617C15F71BD4
P2860
Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Reversal of left ventricular h ...... ndomized double-blind studies.
@en
type
label
Reversal of left ventricular h ...... ndomized double-blind studies.
@en
prefLabel
Reversal of left ventricular h ...... ndomized double-blind studies.
@en
P2093
P1476
Reversal of left ventricular h ...... ndomized double-blind studies.
@en
P2093
A Klingbeil
R E Schmieder
P304
P356
10.1001/JAMA.1996.03530430051039
P407
P577
1996-05-01T00:00:00Z